Literature DB >> 9176678

Therapeutic use of the 193-nm excimer laser in corneal pathologies.

W Förster1, U Atzler, I Ratkay, H Busse.   

Abstract

PURPOSE: To analyze the results of phototherapeutic keratectomy. PATIENTS AND METHODS: We performed 193-nm excimer laser phototherapeutic keratectomy (PTK) in 252 eyes of 216 patients suffering from pain and/or decrease in visual acuity. One hundred and three eyes had recurrent erosions of the cornea, 86 eyes underwent excimer laser smoothing of the cornea after pterygium surgery, 29 eyes had a bandlike keratopathy (25 rough, 4 smooth) and 34 eyes had other pathologic conditions such as amyloidosis of the cornea, anterior corneal dystrophies, scars after injuries, alkali burns, superficial stromal dystrophies and infections. Recurrent erosions and epithelial dystrophies were treated with 15-20 pulses (160-200 mJ/cm2, 8 mm ablation zone) after mechanical abrasion of the epithelium. Removal of corneal opacities and scars required the use of a masking fluid (methyl-cellulose) in different concentrations and slit-lamp control (integrated in the delivery system of the excimer laser).
RESULTS: Some 91% of the eyes with recurrent erosions were recurrence-free. Fifty-two per cent of the eyes with pterygium had recurrences if the baresclera technique was used and 33% of the eyes if a free conjunctival graft was used. The difference was not significant. All of the patients with bandlike keratopathy were pain-free. In 88% of the eyes with special indications the treatment goal was achieved. No positive effect was seen after alkali burn, in a patient with anterior membrane dystrophy (Grayson-Wilbrandt corneal dystrophy) or in a patient with a corneal protuberance. In one patient with scleroperikeratitis a late recurrence of the opacity was observed 3 years after surgery. A loss of best corrected visual acuity was found only in one patient with bullous keratopathy in whom the treatment goal was the reduction of pain. All patients with smooth bandlike keratopathy had an improvement in best corrected visual acuity of at least one line. About 70% of patients with special indications improved by at least one line, up to nine lines. A possible hyperopic shift in all groups could be minimized using a large ablation zone.
CONCLUSION: PTK with the 193-nm excimer laser is a safe and effective treatment for many superficial diseases of the cornea.

Entities:  

Mesh:

Year:  1997        PMID: 9176678     DOI: 10.1007/BF01739639

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  38 in total

1.  Phototherapeutic keratectomy with excimer laser for Reis-Bückler's corneal dystrophy.

Authors:  P J McDonnell; T Seiler
Journal:  Refract Corneal Surg       Date:  1992 Jul-Aug

2.  Clinical strategies for excimer laser therapeutic keratectomy.

Authors:  J H Talamo; R F Steinert; C A Puliafito
Journal:  Refract Corneal Surg       Date:  1992 Jul-Aug

3.  Excimer laser ablation of infectious crystalline keratopathy.

Authors:  R A Eiferman; D R Forgey; Y D Cook
Journal:  Arch Ophthalmol       Date:  1992-01

4.  Phototherapeutic keratectomy in recurrent corneal intraepithelial dysplasia.

Authors:  D Dausch; M Landesz; E Schröder
Journal:  Arch Ophthalmol       Date:  1994-01

5.  [Clinical use of the excimer laser in treatment of surface corneal opacities--therapeutic strategy and case reports].

Authors:  W Förster; S Grewe; H Busse
Journal:  Klin Monbl Augenheilkd       Date:  1993-02       Impact factor: 0.700

6.  Phototherapeutic keratectomy in nine eyes with superficial corneal diseases.

Authors:  T W Hahn; W J Sah; J H Kim
Journal:  Refract Corneal Surg       Date:  1993 Mar-Apr

7.  Reactivation of latent herpes simplex virus by excimer laser photokeratectomy.

Authors:  J S Pepose; K A Laycock; J K Miller; E Chansue; E J Lenze; L A Gans; M E Smith
Journal:  Am J Ophthalmol       Date:  1992-07-15       Impact factor: 5.258

8.  Phototherapeutic keratectomy in recurrent corneal epithelial erosion.

Authors:  D Dausch; M Landesz; R Klein; E Schröder
Journal:  Refract Corneal Surg       Date:  1993 Nov-Dec

9.  Excimer laser treatment of corneal surface pathology: a laboratory and clinical study.

Authors:  D Gartry; M Kerr Muir; J Marshall
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

10.  Phototherapeutic keratectomy for bullous keratopathy.

Authors:  U Thomann; F Meier-Gibbons; I Schipper
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

View more
  6 in total

1.  [Phototherapeutic keratectomy (o-PTK) with 193 nm excimer laser for superficial corneal scars. Prospective long-term results of 31 consecutive operations].

Authors:  A Hafner; B Seitz; A Langenbucher; G O H Naumann
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

2.  Combined phototherapeutic keratectomy and therapeutic contact lens for recurrent erosions in bullous keratopathy.

Authors:  P Y Lin; C C Wu; S M Lee
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

3.  Excimer laser phototherapeutic keratectomy in eyes with anterior corneal dystrophies: preoperative and postoperative ultrasound biomicroscopic examination and short-term clinical outcomes with and without an antihyperopia treatment.

Authors:  Christopher J Rapuano
Journal:  Trans Am Ophthalmol Soc       Date:  2003

4.  Visual morbidity in thirty-four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis).

Authors:  Jayne S Weiss
Journal:  Trans Am Ophthalmol Soc       Date:  2007

5.  Amniotic membrane transplant with superficial keratectomy in superficial corneal degenerations: efficacy in a rural population of north India.

Authors:  Aparna Rao; Uma Sridhar; A K Gupta
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

6.  Recurrent rates and risk factors associated with recurrent painful bullous keratopathy after primary phototherapeutic keratectomy.

Authors:  Ngamjit Kasetsuwan; Kanokorn Sakpisuttivanit; Usanee Reinprayoon; Vilavun Puangsricharern
Journal:  Clin Ophthalmol       Date:  2015-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.